Üsküdar Üniversitesi’nden G20 Zirvesi’ne Destek
Üsküdar Üniversitesi, Almanya’nın Hamburg kentinde 5 Temmuz’da gerçekleştirilen 4’üncü G20 Beyin Girişimi/Nörobilim Zirvesi’ne destek vererek G20’de Türkiye’nin eğitimdeki gururu oldu. Üsküdar Üniversitesi, Almanya’nın Hamburg kentinde 5 Temmuz’da gerçekleştirilen 4’üncü G20 Beyin Girişimi/Nörobilim Zirvesi’ne destek vererek G20’de Türkiye’nin eğitimdeki gururu oldu. Beyin sırlarının, otizm, şizofreni, parkinson, alzheimer v.s. gibi önemli hastalıkların araştırılıp tedavilerinin geliştirilmesi için eski ABD Başkanı Barack Obama’nın 2013 yılında başlattığı Beyin Girişimi Projesi’nde Türkiye’yi 2015’de Üsküdar Üniversitesi temsil etti. Beyin hastalıklarıyla mücadele küresel işbirliği Hamburg’daki Empire Riverside Hotel’de zirvede, dünyanın önde gelen doktorları, mühendisleri, sinir cerrahları, temel ve klinik bilim insanları, bu yıl dördüncüsü düzenlenen N20’yi gerçekleştirmek için toplandı. Beyin haritalaması konusunda çalışmalar yapan küresel birlik ve ittifak kapsamında düzenlenen zirvede dünyanın farklı ülkelerinden yaklaşık 40 bilim insanı bir araya geldi. Zirvede beyin haritalama, görüntüleme, matematiksel modelleme gibi birçok alan tüm yönleriyle ele alındı. Nörobilim dalında G20 Zirvesi’ndeki 20 uzman bilim adamı, küresel işbirliği, ortaklık, veri paylaşımı ve nörolojik bozuklukların ekonomik ve insani maliyetleri ile mücadeleye yönelik fonların dağılımı için çağrıda bulundu. Üsküdar Üniversitesi Rektörü Prof. Dr. Nevzat Tarhan “Psikiyatrik Nörobilimin Geleceği” Sempozyumda NPİstanbul Beyin Hastanesinden Prof. Dr. Kaya Aksoy “Beyin Hastanesinde Nörocerrahinin Kavramı”, Üsküdar Üniversitesi Öğretim Üyesi Doç. Dr. Barış Metin “Brain Park, Nöroteknolojik başlangıçlar için İş Kuluçka Merkezi”, NPİSTANBUL Beyin Hastanesi İnsan Kaynakları Direktörü, Öğr. Gör. Serdar Karagöz “Beyin Hastanesinin gelecek konsepti” başlıkları altında meslektaşlarına bilgi verdiler. Hamburg’daki Fraunhofer Enstitüsü Müdürü, SBMT üyesi ve Başkan Vekili Prof. Dr. Carsten Claussen, Hamburg’da 4’üncüsü gerçekleşen zirvede “SBMT’nin Sinirbilim-20 Girişimi, Beyin Girişimlerinin küresel konsorsiyumlarının oluşturulması ve dünya çapında yıkıcı olan nöro-psikiyatrik bozukluklarla mücadelede bütüncül bir cephe oluşturmak için gerçekten etkileyici bir yaklaşım olduğuna dikkat çekti. Ürkütücü rakamlar SBMT Yönetim Kurulu Başkanı ve Bilim Müdürü, BMF Başkanı, NCNBE Direktörü ve Beyin Teknolojisi ve Yenilik Parkı Müdürü (BTIP) Dr. Babak Kateb, “Nörolojik rahatsızlıkların dünyadaki insani ve finansal maliyeti çok fazla. ABD’de sadece 5.5 milyon Alzheimer hastasının bakım maliyeti yılda 200 milyar dolara yakın ve bu maliyet 10 yıl içinde 1 trilyon dolara yakın olacaktır. 2015 senesinde Demansın dünya ekonomisine maliyeti 818 milyon dolar ve 46,8 milyon civarında hastanın bakımına tekabül ediyordu. Bu rakamlar 2030 senesinde demans için 2 trilyon dolar olacak. Demans bir ülke olsaydı Gayri Safi Yurt İçi Hasılatı (GSYİH) üzerinden 18 numara olurdu” dedi. SBMT, son 15 yılda küresel beyin girişimleri kurma alanının ön saflarında yer alıyor ve Obama’nın Beyin Girişimi’ni formüle etme ve desteklemede anahtar bir oyuncu oldu. – Askerzadeh
Beyin haritalamada küresel işbirliği
Beyin Haritalaması konusunda çalışmalar yapan küresel birlik ve ittifak kapsamında 4’üncü G20 Beyin Girişimi/Nörobilim Zirvesi Almanya’da gerçekleştirilecek. Üsküdar Üniversitesinin de destek verdiği zirvede dünyanın farklı ülkelerinden çok sayıda bilim insanı bir araya gelecek. Zirvede beyin haritalama, görüntüleme, matematiksel modelleme gibi birçok alan tüm yönleriyle ele alınacak. Üsküdar Üniversitesi, Fraunhofer IME Enstitüsü, Beyin Haritalama ve Terapötik Derneği, Beyin Haritalama Derneği ve Nanobiyoelektronik için Ulusal Merkez, G20 Nörobilim Zirvesi kapsamında klinik translasyonel nörobilimi alanında küresel işbirliğini genişletmek için Almanya’nın Hamburg kentinde bir araya gelecek. Nörobilim – G20 Zirvesi’ndeki 20 bilim adamı, küresel işbirliği, ortaklık, veri paylaşımı ve nörolojik bozuklukların ekonomik ve insani maliyetleri ile mücadeleye yönelik fonların dağılımı için çağrıda bulunacak. 5 Temmuz 2017’de dünyanın önde gelen doktorları, mühendisleri, sinir cerrahları, temel ve klinik bilim insanları, Hamburg’daki Empire Riverside Hotel’de 4. Yıllık N20’yi gerçekleştirmek için toplanıyor. Hamburg’daki Fraunhofer Enstitüsü Müdürü, SBMT üyesi ve Başkan Vekili Prof. Dr. Carsten Claussen, Hamburg’da 4’üncüsü gerçekleşecek olan zirveyle ilgili şunları söyledi: “SBMT’nin Sinirbilim-20 Girişimi, Beyin Girişimlerinin küresel konsorsiyumlarının oluşturulması ve dünya çapında yıkıcı olan nöro-psikiyatrik bozukluklarla mücadelede bütüncül bir cephe oluşturmak için gerçekten etkileyici bir yaklaşım.” Üsküdar Üniversitesi Rektörü, SBMT Türkiye Başkanı ve N20 Başkan Yardımcısı Prof. Dr. Nevzat Tarhan, “Üsküdar Üniversitesi, Almanya’daki küresel düşünce liderlerinin bu olağanüstü toplantısına ortak sponsorluk yapmaktan onur duymaktadır. N20 vesilesiyle dünya çapında bilim adamları ile çok taraflı ortaklık kurmak için sabırsızlanıyoruz” dedi. N20 programında beyin haritalama ve görüntüleme, connectomic, matematiksel modelleme ve yapay zekâ nanokorezyase, nörofotonik ve genomik tedavi için terapötik alanlar tüm yönleriyle ele alınacak. Program, bilim adamlarının yeni teşhis ve terapileri hızla tanıtmalarını sağlayacak bilim ve teknoloji disiplinlerinde bilimsel ilerleme alışverişinde bulunmayı amaçlıyor. SBMT Yönetim Kurulu Başkanı ve Bilim Müdürü, BMF Başkanı, NCNBE Direktörü ve Beyin Teknolojisi ve Yenilik Parkı Müdürü (BTIP) Dr. Babak Kateb, “Nörolojik rahatsızlıkların dünyadaki insani ve finansal maliyeti çok fazla. ABD’de sadece 5.5 milyon Alzheimer hastasının bakım maliyeti yılda 200 milyar dolara yakın ve bu maliyet 10 yıl içinde 1 trilyon dolara yakın olacaktır. 2015 senesinde Demansın dünya ekonomisine maliyeti 818 milyon dolar ve 46,8 milyon civarında hastanın bakımına tekabül ediyordu. Bu rakamlar 2030 senesinde demans için 2 trilyon dolar olacak. Demans bir ülke olsaydı Gayri Safi Yurt İçi Hasılatı (GSYİH) üzerinden 18 numara olurdu” dedi. Üsküdar Üniversitesi Rektörü Prof. Dr. Nevzat Tarhan “Psikiyatrik Nörobilimin Geleceği”NPİSTANBUL Beyin Hastanesinden Prof. Dr. Kaya Aksoy “Beyin Hastanesinde Nörocerrahinin Kavramı”, Üsküdar Üniversitesi Öğretim Üyesi Doç. Dr. Barış Metin “BrainPark, Nöroteknolojik başlangıçlar için İş Kuluçka Merkezi”, NPİSTANBUL Beyin Hastanesi İnsan Kaynakları Direktörü, Öğr. Gör. Serdar Karagöz “Beyin Hastanesinin gelecek konsepti” başlıklarında sempozyumda birer konuşma yapacak. SBMT, son 15 yılda küresel beyin girişimleri kurma alanının ön saflarında yer alıyor ve Obama’nın BEYİN Girişimi’ni formüle etme ve desteklemede anahtar bir oyuncu oldu.
Global unity and alliance in Brain Mapping and Therapeutics will be achieved in Germany during the G20 Summit at 4th Annual G20 BRAIN Initiative/Neuroscience-20 symposium
LOS ANGELES, June 27, 2017 /PRNewswire-USNewswire/ — Fraunhofer IME Institute, Uskudar University , the Society for Brain Mapping and Therapeutics (SBMT), Brain Mapping Foundation (BMF), National Center for NanoBioElectronic (NCNBE) have come together in Hamburg, Germany during the G20 Summit to expand global cooperation and partnership on clinical translational neuroscience through Neuroscience-20 (N20) Initiative. “Neuroscience-20 Initiative of SBMT is truly impressive approach toward building global consortia of Brain Initiatives in order to create a united front for tackling devastating neuro-psychiatric disorders worldwide,” said Professor Carsten Claussen, Director of Fraunhofer Institute in Hamburg, a member of SBMT and Vice-Chairman of the 4th Annual N20 in Hamburg Germany. On July 5th 2017, world’s leading physicians, engineers, neurosurgeons, basic and clinical scientists are gathering at the 4th Annual N20 at the Empire Riverside Hotel, Hamburg, Germany. “Uskudar University is truly honored to jointly sponsor this remarkable gathering of global thought-leaders in Germany; we are looking forward to building multilateral partnership with scientists worldwide through N20” Said Professor Nevzat Tarhan, President of Uskudar University, President of SBMT-Turkey and Vice-Chairman of the N20. The 4th annual N20 program covers all aspects of brain mapping and therapeutics from imaging, connectomics, mathematical modeling, and artificial intelligence to nanoneuroscience, neurophotonics and genomics. The program is aimed at exchanging scientific progress across disciplines of science and technology, which could enable scientists rapidly introduce new diagnostics and therapeutics. “The human and financial cost of the neurological disorders to the world is enormous; the cost of care of near 5.5 million Alzheimer’s patients in the US alone is now close to $200 billion annually; this cost will be closer to $1 trillion in 10 years.” said, Dr. Babak Kateb, Founding Chairman of the Board and Scientific Director of SBMT, President of BMF, Director of NCNBE and Director of Brain Technology and Innovation Park (BTIP) “in 2015, the cost of dementia to the world economy was $818 million which corresponds to the care for near 46.8 million patients; in 2030, this cost will be $2 trillion for dementia alone; this means if dementia was a country, it would be number 18 on the Gross Domestic Product (GDP)”. SBMT has been on the forefront of establishing global Brain Initiatives in the last 15 years and was a key player in formulating and supporting Obama’s BRAIN Initiative. Scientific delegations across the G20 will be attending the symposium; the registration for N20 summit will be closed on July 4th 2017. For more details about the program, you can contact Vice President of Brain Mapping Foundation, Ret. Navy Commander Dr. Ken Green at Ken.Green@WorldBrainMapping.Org USA Media Contact:Dr. Ken GreenKen.Green@WorldBrainMapping.Org 202 577-5105 Turkish Media Contact:Öznur Özcan Yıldırımoznur.ozcanyildirim@uskudareurope.com +491746001979 German Media Contact:Dr. Mira GraettingerMira.graettinger@ime.fraunhofer.de +49 (40) 303764-270 About SBMT:www.WorldBrainMapping.Org About BMF:www.BrainMappingFoundation.Org About Uskudar University:http://www.uskudar.edu.tr/en About Fraunhofer Institute for Molecular Biology and Applied Ecology IME:https://www.ime.fraunhofer.de/en.html SOURCE Society for Brain Mapping and Therapeutics Related Links http://www.WorldBrainMapping.Org
Nörobilimin en iyileri G-20’de bir araya geliyor
Beyin haritalama ve tedavileri alanında dünya çapında çalışmaları yakından takip eden Üsküdar Üniversitesi ve NPİSTANBUL Beyin Hastanesi, 5 Temmuz’da Almanya’nın Hamburg şehrinde gerçekleştirilecek SBMT G20 uydu sempozyumuna katılacak. Nörobilim alanında dünyaca otorite bilim insanlarının katıldığı sempozyumda Üsküdar Üniversitesinden Rektör Prof. Dr. Nevzat Tarhan, Prof. Dr. Kaya Aksoy, Doç. Dr. Barış Metin ve Öğr. Gör. Serdar Karagöz de sempozyumda konuşma yapacak. ABD Başkanı Barack Obama’nın 2013 yılında başlattığı Brain İnitiative (Beyin İnisiyatifi) Projesi’nde Türkiye’yi temsil eden ve bu kapsamda Türkiye’de G20 Dünya Beyin Haritalaması ve Tedavileri Bilimsel Zirvesi’ni gerçekleştiren Üsküdar Üniversitesi ve NPİSTANBUL Beyin Hastanesi şimdi SBMT G20 Zirvesi için Almanya’ya gidiyor. SBMT’nin her yıl düzenlediği yıllık toplantısı bu sene 5 Temmuz’da Hamburg, Almanya’da gerçekleşecek. Üsküdar Üniversitesi ana sponsorlardan biri olarak sempozyumda yerini alacak. Beyin haritalama ve tedavileri alanında Tedavisel Beyin Haritalaması Derneği olarak da çalışmalarını sürdüren Üsküdar Üniversitesinden önemli isimler, Empire Riverside Hotel’de gerçekleştirilecek zirvede konuşma yapacak. Bu bağlamda; Üsküdar Üniversitesi Rektörü Prof. Dr. Nevzat Tarhan “Psikiyatrik Nörobilimin Geleceği”NPİSTANBUL Beyin Hastanesinden Prof. Dr. Kaya Aksoy “Beyin Hastanesinde Nörocerrahinin Kavramı”,Üsküdar Üniversitesi Öğretim Üyesi Doç. Dr. Barış Metin “BrainPark, Nöroteknolojik başlangıçlar için İş Kuluçka Merkezi”,NPİSTANBUL Beyin Hastanesi İnsan Kaynakları Direktörü, Öğr. Gör. Serdar Karagöz “Beyin Hastanesinin gelecek konsepti” başlıklarında sempozyumda birer konuşma yapacak. G20 Dünya Beyin Haritalama ve Terapötik Bilimsel Zirvesi, eski Başkan Obama’nın Beyin girişimine katkıda bulunmayı hedeflemesi ile başlayan süreçte G20 ülkelerindeki mevcut ve gelecekteki girişimleri hakkında harekete geçmeyi amaçlıyor.Nörobilim alanında dünyadaki en iyi bilim adamları, mühendisleri, doktorları ve cerrahları bir araya getiren bu zirvede, dünya ekonomisine her yıl milyar dolara mal olan nörolojik rahatsızlıklara klinik tedaviler bulma amacıyla bir araya geliyor. Ayrıntılı Bilgi İçin: Üsküdar Haber Ajansı (ÜHA)
14th Annual Brain Mapping Foundation Conference and Gala
By Valerie Milano Los Angeles, CA (The Hollywood Times) 4/25/17-“As an entertainment attorney, I deal with contracts, contracts and more contracts. While it’s great to assist my clients in protecting their talent, creations and years of hard work, serving as the legal advisor and advisory board member of the Brain Mapping Foundation, however, I get to advise Dr. Kateb, a brilliant neuroscientist and his wise colleagues create technologies and bring awareness to life threatening diseases. I’m delighted to be involved with a cause that effects nearly all of us,” said Nadia Davari. The Society for Brain Mapping and Therapeutics (“SBMT”), Brain Mapping Foundation (“BMF”), and the National Center for NanoBioElectonics (“NCNBE”) held their 14th Annual World Brain Mapping and Therapeutics Conference at the Millennium Biltmore Hotel in downtown Los Angeles. SBMT was founded in 2004 to break boundaries in healthcare and to promote global interdisciplinary research to improve the diagnosis, treatment, and rehabilitation of patients with central nervous system diseases and disorders. “This year, there were 320 speakers and 12 keynote speakers who will address state-of-the-art brain science and technology, and pioneering diagnostics therapeutics for Alzheimer’s Disease, Parkinson’s Disease, brain and spinal trauma, brain cancer, psychiatric disorders, the Autism spectrum, Post-Traumatic Stress Disorder (“PTSD”), as well as all other neurological disorders,” said Dr. Wes Ashford, Clinical Professor of Stanford University (affiliated), Director of The War Related Illness & Injury Study Center at the VA Palo Alto HCS and the 14th President of SBMT (2016-17). “This year, several sessions of the conference focused on translation, integration and development of advanced diagnostics and therapeutics for soldiers, veterans and civilians with neurological disorders.” Annually, the Society and the Brain Mapping Foundation recognize pioneers in the field of brain mapping and therapeutics with distinguished awards. The Brain Mapping Foundation held its “Gathering for the Cure” black tie gala on Thursday, April 20th at the Millennium Biltmore Hotel to celebrate pioneering work of some of the world’s leading scientists, technologists, policymakers, and science advocates. “We had a very competitive pool of applicants this year who are truly remarkable individuals as people and pioneers in their respective fields for which they were selected,” said Dr. Vicky Yamamoto, USC-Keck School of Medicine Cancer Scientist, Executive Director of SBMT, Member of the Board of Brain Mapping Foundation and Co-chair of the Award Committee. “We are truly delighted to have recognized the contributions of these colleagues to the field of clinical neuroscience.” The 2017 award recipients were as follows: Professors George Ojemann (Pioneer in epilepsy neurosurgery) and John Adler (inventor of Cyberknife) the recipients of the Pioneer in Medicine award; Congressman Jerry McNerney the recipient of Pioneer in Healthcare Policy Award, Professor Afsaneh Rabiei is recipient of the Pioneer in Technology Development; Travis Roy recipient of Beacon of Courage and Dedication; Golden Axon award for leadership is given to Drs. Wes Ashford (2016-17 President of SBMT), Michael Roy (2012-13 President of SBMT) and Drs. Nasser Kashou, Ajeet Kaushik, Alexander Stahn are the recipients of Young Investigator award. The scientific program of 2017 SBMT annual meeting has 320 speakers and 12 keynote speakers including Congressman Jerry McNerney, Space Traveler and Engineer Anousheh Ansari, Drs. Gary Small (UCLA), Laligam Sekhar (UW), George Ojemann (UW), Mark Humayun (USC), Wes Ashford (Stanford/VA Palo Alto HCS), Warren Boling (LLU), Kyu Rhee (IBM Watson Health), Dean Yamaguchi (Department of Veterans Affairs), and RADM Colin Chinn (Defense Health Agency). “The Brain Mapping Foundation has been on the forefront of wounded warrior care for 14 years by bringing together world leading scientists” said Ret. Navy Commander Dr. Ken Green. “We have engaged NASA centers, NASA Human Health and Performance, National Labs, Departments of Energy, Commerce, State, Defense, Navy, Army, Air Force, and Defense Health Agency, in our G20 Global Brain Mapping Initiative (Neuroscience-20) aimed at rapidly introducing diagnostics and therapeutics in the field.” Many Hollywood celebrities were in attendance at the gala including Tim Kring, Jim Kwik, Matthew Rhodes, Charlie Corwin, James Hong, Kate Linder, Mel Novak, Aki Aleong, Navid Negahban, Ken Davitian, Eden Sassoon, Gary Graham, Jimmy Jean-Louis, James Kyson, Dru Mouser, Vida Ghaffari, Alison Arngrim, Max Amini, NFL player Alec Ogletree, former NFL player Jarrod BunchAndrew Jang, Tony Denison, Rachel Sterling of Pussycat Dolls, Shanica Knowles, Sean Kanan, Apick Youssefian, Mary Apick, fashion designer Sue Wong, and entrepreneur and publisher Miguel R. Forbes. For more information about the foundation and to donate to such a worthwhile cause, please visit: www.BrainMappingFoundation.Org All photos courtesy of Bob Delgadillo/PR Photos and We Got You Media
Üsküdar University is in USA to attend the SBMT 14th Annual Congress
The 14th Annual World Congress of SBMT will bring together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies (operative and non-operative). The conference will take place at the Millennium Biltmore Hotel in LA (April 18th to April 20th 2017) in the metropolitan city of Los Angeles, California on the West Coast of the United State of America. Prof. Nevzat Tarhan will attend the Congress as one of the speakers. The conference aim is to create a critical mass by introducing synergy amongst inter-disciplinary researchers to further understand the brain function and nervous system. It will serve as a platform from which to develop interactions between many of the stakeholders who also have extensive collaborations at national and international levels. The conference provides the opportunity to be at the forefront of brain sciences, therapeutics in general and neural stem cells interventions in particular. It provides a strong platform for industry and biotech companies to interact with academia in frontiers of science in this field for translational initiatives involving diverse patient’s interest groups. Üsküdar University will attend the Congress among the well-known scientists. Prof. Nevzat Tarhan, Associate Prof. Barış Metin, Associate Prof. Cumhur Taş, Assistant Prof. Rüştü Murat Demirer and research assistant Merve Çebi will deliver their speeches in the Congress. The titles of their presentations are listed below;Prof. Nevzat Tarhan: Biomarkers that can be used for personalized treatment of psychiatric disordersDoç. Barış Metin: MRI biomarkers: Can functional neuroimaging improve diagnostic accuracy in psychiatry?Associate Prof. Cumhur Taş: Beyond theta/beta ratio: The future of EEG in psychiatryAssistant Prof. Rüştü Murat Demirer: Advanced signal processing methods for EEG analysisResearch Assistant Merve Çebi: Use of tractography to differentiate neuropsyciatric disorders Topics covered including: For further information: https://www.worldbrainmapping.org/Annual-Congress/ Üsküdar News Agency (ÜNA)
Hollywood Meets Medicine, Science, Art, Technology, and Policy in LA LA Land
LOS ANGELES, April 17, 2017 /PRNewswire-USNewswire/ — The Society for Brain Mapping and Therapeutics (“SBMT”), Brain Mapping Foundation (“BMF”), and the National Center for NanoBioElectonics (“NCNBE”) will hold their 14th Annual World Brain Mapping and Therapeutics Conference at the Millennium Biltmore Hotel in downtown Los Angeles. SBMT was founded in 2004 to break boundaries in healthcare and to promote global interdisciplinary research to improve the diagnosis, treatment, and rehabilitation of patients with central nervous system diseases and disorders. “This year, there are 320 speakers and 12 keynote speakers who will address state-of-the-art brain science and technology, and pioneering diagnostics therapeutics for Alzheimer’s Disease, Parkinson’s Disease, brain and spinal trauma, brain cancer, psychiatric disorders, the Autism spectrum, Post-Traumatic Stress Disorder (“PTSD”), as well as all other neurological disorders,” said Dr. Wes Ashford, Clinical Professor of Stanford University (affiliated), Director of The War Related Illness & Injury Study Center at the VA Palo Alto HCS and the 14th President of SBMT (2016-17). “This year, several sessions of the conference will focus on translation, integration and development of advanced diagnostics and therapeutics for soldiers, veterans and civilians with neurological disorders.” Annually, the Society and the Brain Mapping Foundation recognize pioneers in the field of brain mapping and therapeutics with distinguished awards. The Brain Mapping Foundation is holding its “Gathering for the Cure” black tie gala on Thursday, April 20th at the Millennium Biltmore Hotel to celebrate pioneering work of some of the world’s leading scientists, technologists, policymakers, and science advocates. “We had a very competitive pool of applicants this year who are truly remarkable individuals as people and pioneers in their respective fields for which they were selected,” said Dr. Vicky Yamamoto, USC-Keck School of Medicine Cancer Scientist, Executive Director of SBMT, Member of the Board of Brain Mapping Foundation and Co-chair of the Award Committee. “We are truly delighted to recognize the contributions of these colleagues to the field of clinical neuroscience.” The 2017 award recipients are as follows: Professors George Ojemann (Pioneer in epilepsy neurosurgery) and John Adler (inventor of Cyberknife) the recipients of the Pioneer in Medicine award; Congressman Jerry McNerney the recipient of Pioneer in Healthcare Policy Award, Professor Afsaneh Rabiei is recipient of the Pioneer in Technology Development; Travis Roy recipient of Beacon of Courage and Dedication; Golden Axon award for leadership is given to Drs. Wes Ashford (2016-17 President of SBMT), Michael Roy (2012-13 President of SBMT) and Drs. Nasser Kashou, Ajeet Kaushik, Alexander Stahn are the recipients of Young Investigator award. Dr. Peter Diamandis, Chairman of XPrize, is the keynote speaker at the Brain Mapping Foundation “Gathering for Cure” gala who will be speaking about global innovation. “SBMT and its science committee includes over 80 scientists that have built this program over the last 16 months”, said the 2018 President Elect of SBMT, Dr. Warren Boling, chairman of the Department of Neurosurgery at Loma Linda University (“LLU”). He added “LLU, City of Hope, and Cedars Sinai Medical Center co-sponsored this world class scientific program for its Continuing Medical education (“CME”) accreditation.” This remarkable scientific program is supported by industry leaders including: Fiagon, Fulgent Diagnostics, Space Bio-Laboratories Co., Ltd, Siemens Healthcare, Medtronic, Codman, Stryker, KLS Martin, Ad-Tech, Zeiss, Anatom-e, Nordic Neuro Lab (“NNL”), Synaptive Medical, Integra , PMT Corporation, HarleQuin Recruiting, Med Valley Home Healthcare Inc, Jupiter 9 Production, CariCord, Neurotrope BioScience, California Neurosurgical Institute, Nuvasive, the Law office of Nadia Davari, Planet Street Digital Marketing, Apex Photo Studios, Keri Ann Kimball of Kimball Entertainment, Joe Williamson of Williamson Management, SoVeryVida and Neuronavigation Dinamics. The scientific program of 2017 SBMT annual meeting has 320 speakers and 12 keynote speakers including Congressman Jerry McNerney, Space Traveler and Engineer Anousheh Ansari, Drs. Gary Small (UCLA), Laligam Sekhar (UW), George Ojemann (UW), Mark Humayun (USC), Wes Ashford (Stanford/VA Palo Alto HCS), Warren Boling (LLU), Kyu Rhee (IBM Watson Health), Dean Yamaguchi (Department of Veterans Affair), and RADM Colin Chinn (Defense Health Agency). “The Brain Mapping Foundation has been on the forefront of wounded warrior care for 14 years by bringing together world leading scientists” said Ret. Navy Commander Dr. Ken Green. “We have engaged NASA centers, NASA Human Health and Performance, National Labs, Departments of Energy, Commerce, State, Defense, Navy, Army, Air Force, and Defense Health Agency, in our G20 Global Brain Mapping Initiative (Neuroscience-20) aimed at rapidly introducing diagnostics and therapeutics in the field.” Many Hollywood celebrities including: (event host) Robert Picardo, Tim Kring, Jim Kwik, Matthew Rhodes, Charlie Corwin, James Hong, Kate Linder, Hank Garrett, Mel Novak, Aki Aleong, Navid Negahban, Ken Davitian, Eden Sassoon, Gary Graham, Jimmy Jean-Louis, James Kyson, Dru Mouser, Sophia Milos, Vida Ghaffari, Alison Arngrim, Jarrod Bunch, Max Amini, NFL player Alec Ogletree, Andrew Jang, Tony Denison, Rachel Sterling of Pussycat Dolls, Shanica Knowles, Sean Kanan, Apick Youssefian, Mary Apick, fashion designer Sue Wong, and entrepreneur and publisher Miguel R. Forbes will be in attendance at the “Gathering for Cure” gala. For more information about the “Gathering for Cure” gala registration and donation to the foundation please visit: www.BrainMappingFoundation.Org and for more information about the Society and convention registration for the 14th Annual World Brain Mapping Conference and Gala please visit: www.WorldBrainMapping.Org Contact: Dr. Harry Kloor; Charry@J9Pro.Com 818-679-4009 Media Contact: Joseph Kelbie Williamson 818-605-8886 williamsonmgmt@gmail.com SOURCE Society for Brain Mapping and Therapeutics (SBMT) Related Links https://www.worldbrainmapping.org/
LLU neurosurgery professor briefs congressional caucus
When the U.S. Congressional Neuroscience Caucus hosted the sixth annual Brain Mapping Day briefing March 8 in Washington, D.C., a Loma Linda University professor was one of only seven experts from across the nation who spoke. Warren Boling Jr., MD, chair of neurosurgery at Loma Linda University Health, illuminated the topic of “Intraoperative Brain Mapping for Brain Tumor and Epilepsy.” Much of what he presented he drew from Loma Linda’s data about the rapidly evolving use of functional MRI and diffusion tensor imaging to make brain surgery safer and more effective. “We had a good reception from our legislative members who attended and then had excellent follow up conversations with staff members for California Sen. Kamala Harris,” Boling said. “We also had a wonderful meeting with U.S. Rep Pete Aguilar, talking about Loma Linda University Health and the great things we’re doing for the Inland Empire.” The other speakers at the briefing also presented “groundbreaking and forward-thinking advances in the neurosciences,” Boling said. He is also president-elect for the Society for Brain Mapping and Therapeutics, which organized the meeting. His one-year term will begin in April, marking the first time someone from Loma Linda has held such a high position with the society. Boling summarized, “It was important for our legislators to hear about the obstacles and difficulties that we’re having in improving patient care as well as the advances we’re making and the exciting new things that are coming to improve the lives of our patients with neurological diseases. “In the future we can tackle more complicated problems using these advanced mapping and imaging techniques.”
BRAIN Initiative Leader is Recognized by Leading Brain Mapping Association and Foundation; SBMT and BMF Calls for Formation of Brain Technology and Research Parks as well as Global Collaboration on Technology Development and Data sharing
LOS ANGELES, April 29, 2016 /PRNewswire-USNewswire/ — More than 400 scientists, engineers, physicians and surgeons gathered at the Miami Convention Center last week to discuss pioneering technology and science in the fields including: art of innovation and data-sharing, multimodality imaging, nanoneurosurgery, nanobioelectronics, neurophotonics, cellular therapeutics (stem cell and neuro-immunotherapey), supercomputing, robotics (brain computer interface), neural transplantation and repair (double hand transplants), neuroengineering, Artificial Intelligence (AI), augmented reality and virtual reality in clinical neuroscience as well as computational and predictive modeling. The 2016 convention was supported by X2 BioSystems, Inc., Surgical Theater, Medtronic, Stryker, EIZO , Haag-Streit USA, Time Medical Systems, Nordic NeuroLab, PMT Corporation, Monteris Medical Inc, and Compumedics, Brain Mapping Foundation (BMF) and Society for Brain Mapping and Therapeutics (SBMT). The 13th Annual World Congress of SBMT covered majority of neurological diseases such as brain cancer, neurotrauma (including Chronic Traumatic Encephalopathy and Traumatic Brain Injury), psychiatric disorders, neurodegenerative disorders (including Parkinson’s & Alzheimer’s diseases). SBMT and Brain Mapping Foundation (BMF) also recognized pioneering scientific works by Drs. Ted Berger (USC) for his pioneering work in Brain Computer Interface, Bennet Omalu (UCD) for discovering Chronic Traumatic Encephalopathy in retired NFL football players, Aaron Filler (Institute for Nerve Medicine) for his pioneering work in Diffusion Tensor Imaging/neuro Imaging. “I am thrilled to receive this honor from the SBMT, and I accept it on behalf of the entire team of engineers, neuroscientists and physicians who have been working with me to create a cognitive prosthesis to recover lost memory function that is now being tested in human patients,” said Dr. Ted Berger, Professor of Biomedical Engineering at University of Southern California. “By recognizing interdisciplinary work on brain-computer interfaces, the SBMT brings into focus next-generation research that will push the envelope of neural system repair to include medical devices that bi-directionally communicate with the brain so as to recover higher thought processes so often ravaged by diseases such as Alzheimer’s. We look forward to completing the first clinical tests of this memory prosthesis, and ultimately bringing the rewards of this research to the public,” he continued. The Pioneer in Technology Development Award was presented to Dr. John Ralston, Chairman President and CEO of X2 BioSystems, Inc., and Dr. Chenzhong Li, Florida International University for their pioneering work in designing and engineering a sensor to measure G-force to the brain of athletics and soldiers (Dr. Ralston at X2 BioSystems) and beta-amyloid in brain of patients with Alzheimer’s disease (Dr. Li at FIU). “I am honored and humbled to have this award given by SBMT. As a professor of Biomedical Engineering, I am more interested in translational research such as the micro immune biosensor, which enable us to monitor Alzheimer’s disease biomarker in and out of brain,” Dr. Chenzhong Li, Professor of Biomedical Engineering at FIU. Corporal William Kyle Carpenter, USMC (ret), the youngest living recipient of the Congressional Medal of Honor, received SBMT’s Beacon of Courage and Dedication Award. Every year SBMT and BMF recognize the pioneering work by policy makers who have contributed significantly to the progress of the field of Brain Mapping and Therapeutics. “The award committee of SBMT and BMF is delighted to present the 2016 Prestigious Pioneer award to our colleagues including Congressman Dr. Andy Harris who has been a great leader and supportive of the BRAIN Initiative and the G20 World Brain Mapping and Therapeutics Initiative,” said, Dr. Vicky Yamamoto, a newly appointed Executive Director of SBMT, a cancer scientist and a member of the Executive Board of SBMT. Past recipients of the Pioneer in Healthcare Policy award include Co-chair of Congressional Neuroscience Caucus: Congresswoman Mc Morris Rodgers and Congressman Blumenauer, Congressman Fattah, Secretary of State Honorable John Kerry, Science Minister of Canada Honorable Kirsty Duncan. Honorable Congressman Andy Harris was also a keynote speaker at 2016 Annual World Brain Mapping of SBMT in Miami, which he spoke about adjusting the model of the government funding agencies to the 21st century so that younger scientists who are innovative could be supported and collaborations with organizations like SBMT that are on the forefront of innovation could be fostered. “I am honored by this recognition and encouraged by the amazing science and technology presented at the Brain Mapping day on Capitol Hill, which was a snapshot of the 13th annual World Congress of SBMT in Miami. I am also supportive of a continued global partnership in science,” said Congressman Andy Harris, M.D. The 2016 Pioneer in Healthcare Policy award was presented by the scientific delegation of SBMT to the Honorable Congressman Dr. Andy Harris at the 5th Annual Brain Mapping Day at the US Congress, which was held at the Rayburn House office building on April 20Th 2016. The Program was jointly sponsored by Congressional Neuroscience Caucus, SBMT, BMF, National Center for NanoBioElectronic, X2 BioSystems and SAP. “G20+/N20+ World Brain Mapping Initiative aims to fundamentally change the culture of scientific innovation and discovery. We mean it when we talk about collaboration and breaking walls and silos of group thinking amongst associations and scientific groups. We also believe that there is a great need for formation of Brain Research and Technology Parks, which could globally facilitate and interconnect our efforts to discover brain functions and dysfunctions,” said Dr. Babak Kateb, Founding Chairman of the Board, CEO and Scientific Director of SBMT, Scientific Director and Director of Strategic Alliance at California Neurosurgical Institute, President of Brain Mapping foundation, Visiting Scientist at NASA/JPL and Director of National Center for NanoBioElectronics, CA, USA. At the Brain Mapping Day, scientist, engineers, and surgeons briefed the Congressional leaders and their staff about the latest advances in the field and advised the leaders to encourage global collaboration through G20+/N20+ (Neuroscience 20+) World Brain Mapping and Therapeutics Initiative and allocate funding for the USA BRAIN Research and Technology Parks. “Our G20+/N20+ Word Brain Mapping Initiative is aimed at the global partnership for Brain Mapping and Therapeutics; we already have started building strategic alliances globally and expanding our Brain Research and Technology Parks in Australia, China, Middle East and hope the US catch up with these efforts soon,” said Dr. Kuldip Sidhu, Vice Chairman of the G20+/N20+ World Brain Mapping and Therapeutics Initiative, Past President of SBMT, President of World Brain Mapping Foundation-Australia and member of the Executive Board of SBMT; Associate Professor of Stem Cell at UNSW, Sydney Australia. Press ContactDr. Vicky YamamotoCancer Scientist &Executive Director of SBMTVYamamot@Med.USC.Edu 310-500-6196 About SBMT:www.WorldBrainMapping.Org
X2 Biosystems Presents at 5th Annual Brain Mapping Day at the US Congress
REDWOOD CITY, Calif. and WASHINGTON, April 21, 2016 /PRNewswire/ — X2 Biosystems, the leader in head impact safety solutions, today announced their participation at the 5th Annual Brain Mapping Day at the US Congress on April 20 in Washington, D.C. The event was organized by the Society for Brain Mapping and Therapeutics (SBMT), the Brain Mapping Foundation (BMF), the National Center for NanoBioElectronics, and the Congressional Neuroscience Caucus. During his presentation, X2 Chairman and CEO John Ralston, Ph.D., highlighted opportunities to correlate data from wearable head-impact sensors with computerized impact simulations and high resolution brain mapping to monitor, assess, and reduce the risks of brain injury in athletic and military environments. “We are honored to have this opportunity to support the efforts of SBMT and share our work with the Congressional Neuroscience Caucus,” said Dr. Ralston. “Combining X2’s wearable impact sensor solutions with high-performance data analytics platforms will enable significant breakthroughs in correlating real-time head impact data with multiple additional data streams, both at the network edge and in the cloud, to significantly enhance brain health and safety during athletic and military training exercises and sporting events.” The wide range of impairments to cognitive, motor, and sensory functions that can result from repetitive head impacts, often coupled with additional emotional and behavioral symptoms, has become recognized as an enormous public health challenge. Although much recent focus has been directed specifically at the issue of concussion injuries, a growing body of research is revealing that significant long-term brain injuries may result from cumulative head impacts even in the absence of clinically diagnosed concussion symptoms. In order to address this challenge, X2 Biosystems is developing solutions that combine the company’s “X-Patch” wearable head impact sensors with high-performance analytics platforms to address important goals such as: “We are grateful for the participation of industry leaders such as X2 Biosystems at the 5th Annual Brain Mapping Day,” said Aaron Filler, M.D., Ph.D., J.D., President of SBMT. “This is a fine example of government, industry, academia, and non-profit partnership to drive collaboration across multiple scientific and engineering disciplines, and to facilitate rapid introduction of life saving technologies for brain health, fitness, and therapeutics.” About X2 Biosystems (http://www.x2bio.com)X2 Biosystems merges wearable impact monitoring devices, neurocognitive assessment tools, wireless communications, and cloud data analytics to deliver the complete continuum of care in concussion management that athletic, medical, military, and industrial markets are now demanding in order to reduce the incidence, risks, and costs of head impacts and concussion injuries. X2 has offices in Redwood City, CA, and Seattle, WA. About The Society for Brain Mapping and Therapeutics (SBMT)(https://www.worldbrainmapping.org/about-sbmt) The Society for Brain Mapping and Therapeutics (SBMT) is a non-profit society organized for the purpose of encouraging basic and clinical scientists who are interested in areas of brain mapping, engineering, stem cell, nanotechnology, imaging and medical device to improve the diagnosis, treatment and rehabilitation of patients afflicted with neurological disorders. The society promotes the public welfare and improves patient care through the translation of new technologies/therapies into lifesaving diagnostic and therapeutic procedures. The society is committed to excellence in education and scientific discovery. The society achieves its mission through multi-disciplinary collaborations with government agencies, patient advocacy groups, educational institutes, industry, and philanthropic organizations. SOURCE X2 Biosystems Related Links http://www.x2biosystems.com